Praxis Precision Medicines (PRAX) free cash flow

Free cash flow · fiscal 2025
-$249.12M

Praxis Precision Medicines (PRAX) generated free cash flow of -$249.12M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$131.76M. Figures as of 18 Nov 2026, 12:16 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$249.12M
Highest on record
-$33.52Mfiscal 2019
Lowest on record
-$249.12Mfiscal 2025
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Praxis Precision Medicines free cash flow, in more detail

Across the 7 fiscal years on record (2019–2025), the highest was -$33.52M in fiscal 2019 and the lowest -$249.12M in fiscal 2025.

History · 7 fiscal years

Free cash flow by fiscal year

Praxis Precision Medicines free cash flow, year by year

Praxis Precision Medicines (PRAX) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$249.12M—
2024-$131.76M—
2023-$111.19M—
2022-$185.49M—
2021-$125.60M—
2020-$52.62M—
2019-$33.52M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Praxis Precision Medicines and comparable companies
CompanyFree cash flowFiscal year
Oscar Health OSCR$1.06B2025
TG Therapeutics TGTX-$24.99M2025
Praxis Precision Medicines PRAX-$249.12M2025
Twist Bioscience TWST-$95.96M2026
Protagonist Therapeutics PTGX$56.08M2025
Krystal Biotech KRYS$188.91M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PRAX

Praxis Precision Medicines, figure by figure

Praxis Precision Medicines (PRAX) overview: price, valuation and scorecardAll health care companies by market value

Praxis Precision Medicines free cash flow: questions and answers

What is Praxis Precision Medicines's free cash flow?

Praxis Precision Medicines (PRAX) generated free cash flow of -$249.12M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$131.76M.

What are the highest and lowest free cash flow figures on record for Praxis Precision Medicines?

Across the 7 fiscal years on record (2019–2025), the highest was -$33.52M in fiscal 2019 and the lowest -$249.12M in fiscal 2025.

How is Praxis Precision Medicines's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Praxis Precision Medicines it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Praxis Precision Medicines (PRAX) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/PRAX/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.